Cargando…
Precision nicotine metabolism-informed care for smoking cessation in Crohn’s disease: A pilot study
INTRODUCTION: Smoking is a strong risk factor for disease severity in Crohn’s disease (CD) and cessation improves outcomes. The nicotine metabolite ratio (NMR) predicts cessation success with pharmacotherapy: varenicline doubles cessation over nicotine replacement therapy (NRT) for “normal”, but not...
Autores principales: | Scoville, Elizabeth A., Tindle, Hilary A., Wells, Quinn S., Peyton, Shannon C., Gurwara, Shelly, Pointer, Stephanie O., Horst, Sara N., Schwartz, David A., Adams, Dawn W., Freiberg, Matthew S., Gatskie, Vanessa, King, Stephen, Abney, Lesa R., Beaulieu, Dawn B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098646/ https://www.ncbi.nlm.nih.gov/pubmed/32214373 http://dx.doi.org/10.1371/journal.pone.0230656 |
Ejemplares similares
-
Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn’s Disease
por: Scoville, Elizabeth A., et al.
Publicado: (2019) -
A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease
por: Bennett, Audrey, et al.
Publicado: (2020) -
Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of Life
por: Coe, Christopher L, et al.
Publicado: (2020) -
Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study
por: Basil, Miles, et al.
Publicado: (2021) -
Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia
por: Tindle, Hilary A., et al.
Publicado: (2020)